Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial

Bevacizumab is frequently used in the treatment of recurrent WHO grade II and III glioma, but without supporting evidence from randomised trials. Ther…

Saved in:

Bibliographic Details
Main Authors:	Van den Bent, Martin J. (Author) , Smits, Marion (Author) , Reijneveld, Jaap (Author) , French, Pim (Author) , Clement, Paul (Author) , Vos, Filip (Author) , Wick, Antje (Author) , Mulholland, Paul (Author) , Taphoorn, Martin (Author) , Lewis, Joanne (Author) , Weller, Michael (Author) , Chinot, Olivier (Author) , Kros, Johan (Author) , Heer, Iris (Author) , Verschuere, Tina (Author) , Coens, Corneel (Author) , Golfinopoulos, Vassilis (Author) , Gorlia, Thierry (Author) , Idbaih, Ahmed (Author)
Format:	Article (Journal)
Language:	English
Published:	August 13, 2018
In:	The lancet. Oncology Year: 2018, Volume: 19, Issue: 9, Pages: 1170-1179
ISSN:	1474-5488
DOI:	10.1016/S1470-2045(18)30362-0
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/S1470-2045(18)30362-0 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1470204518303620
Author Notes:	Martin Bent, Marion Smits, Jaap Reijneveld, Pim French, Paul Clement, Filip Vos, Antje Wick, Paul Mulholland, Martin Taphoorn, Joanne Lewis, Michael Weller, Olivier Chinot, Johan Kros, Iris Heer, Tina Verschuere, Corneel Coens, Vassilis Golfinopoulos, Thierry Gorlia, Ahmed Idbaih

Description
Summary:	Bevacizumab is frequently used in the treatment of recurrent WHO grade II and III glioma, but without supporting evidence from randomised trials. Ther…
Item Description:	Gesehen am 10.03.2020
Physical Description:	Online Resource
ISSN:	1474-5488
DOI:	10.1016/S1470-2045(18)30362-0